Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(4):256-257.EH
Links
MeSH
Pub Type(s)
Letter
Comment
Language
eng
PubMed ID
32347923
Citation
Jeevaratnam, Kamalan. "Chloroquine and Hydroxychloroquine for COVID-19: Implications for Cardiac Safety." European Heart Journal. Cardiovascular Pharmacotherapy, vol. 6, no. 4, 2020, pp. 256-257.
Jeevaratnam K. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety. Eur Heart J Cardiovasc Pharmacother. 2020;6(4):256-257.
Jeevaratnam, K. (2020). Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety. European Heart Journal. Cardiovascular Pharmacotherapy, 6(4), 256-257. https://doi.org/10.1093/ehjcvp/pvaa041
Jeevaratnam K. Chloroquine and Hydroxychloroquine for COVID-19: Implications for Cardiac Safety. Eur Heart J Cardiovasc Pharmacother. 2020 07 1;6(4):256-257. PubMed PMID: 32347923.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
A1 - Jeevaratnam,Kamalan,
PY - 2020/04/08/received
PY - 2020/04/15/revised
PY - 2020/04/21/accepted
PY - 2020/4/30/pubmed
PY - 2020/7/21/medline
PY - 2020/4/30/entrez
SP - 256
EP - 257
JF - European heart journal. Cardiovascular pharmacotherapy
JO - Eur Heart J Cardiovasc Pharmacother
VL - 6
IS - 4
SN - 2055-6845
UR - https://www.unboundmedicine.com/medline/citation/32347923/Chloroquine_and_hydroxychloroquine_for_COVID_19:_implications_for_cardiac_safety_
DB - PRIME
DP - Unbound Medicine
ER -